VIDEO: Thoracic oncologist highlights key lung cancer studies to watch at ASCO
Click Here to Manage Email Alerts
Charu Aggarwal, MD, MPH, shared with Healio non-small cell lung cancer studies she is most looking forward to seeing the results of at the ASCO Annual Meeting, taking place June 3-7 in Chicago.
She specifically is interested in studies evaluating immunotherapy for patients with metastatic NSCLC, especially those without driver alterations; combination immunotherapy in the second-line setting; treatments for patients with brain metastases; and use of circulating-tumor DNA to guide treatment, among other studies.
“There has been so much excitement around this annual meeting, not just for reasons to see old friends, colleagues and networking, but also what brings the annual meeting alive is really presentation of practice-changing data,” Aggarwal said.
Collapse
Healio Interviews
Click Here to Manage Email Alerts